A federal jury in Delaware was asked to settle the boundary between what Arm licenses and what Qualcomm owns outright. After deliberating, the panel told the judge it could not settle it.
The jury failed to reach a verdict in the chip-licensing dispute between Qualcomm and Arm, and the judge scheduled deliberations to resume on October 13, U.S. Eastern time. Reuters reported the standoff across three days, from October 9 through October 11. Neither company got the ruling it came to court for, and the case now sits where it stood when closing arguments ended.
The fight is over the boundary of Arm’s technology-licensing terms, the language setting how much of Arm’s design a customer may fold into its own silicon and at what price. The potential damages run into the billions of dollars. A jury that cannot agree leaves that money, and the contract language behind it, unresolved for now.
When a panel cannot reach a verdict, a judge has a narrow set of options. The court can send the jurors back with instructions to try once more, or declare a mistrial and leave the parties to weigh a second trial against a settlement. Both routes cost time a chip road map rarely has to spare. Until the question is answered, each company has to plan as though the terms of its own deal could still move.
For Qualcomm, the dispute reaches its architecture plans. The company designs its own processor cores for phones, personal computers and a growing share of data-center silicon, and the case tests how far its license lets it build on Arm’s technology without paying more or asking permission. For Arm, the outcome measures the reach of the model that funds the company: licensing designs to partners and collecting royalties on the chips those partners sell.
The ruling matters beyond these two companies because Arm’s agreements are drafted from a common template. Every licensee reads a court decision as a signal about what identical clauses mean in its own contract. A jury that splits on the question leaves the template intact but unread, which is a comfortable outcome for no one who builds on Arm’s instruction set.
The standoff also arrives at a strained moment in a long partnership. Arm has pushed further into selling its own designs and compute subsystems, a direction that has made some licensees uneasy about a supplier that can also become a competitor. A licensing fight that reaches a jury makes that tension explicit: two companies disagreeing, in public, about where one business ends and the other begins.
Neither side has said how it will proceed if the deadlock holds. A second trial would put the same evidence in front of a new panel and hope for a different ending. A settlement would mean both companies accept a number and a set of terms they had refused to accept before the first juror was seated. The judge’s decision to resume discussion on October 13 keeps the first option alive for at least another day.
For the industry, the case serves as a live test of how much control a design licensor can keep over the chips built from its work. Arm prices its royalties on the assumption that its terms are enforceable and clear. Qualcomm prices its products on the assumption that its license covers what it ships. A hung jury leaves both assumptions resting on nothing firmer than the next hearing.
Licensing has become one of the sharper risks in the chip business as design and manufacturing have pulled apart. Companies that once built everything in-house now buy designs, contract out the production and assemble the pieces, which leaves each of them exposed to the terms of someone else’s contract. The Qualcomm and Arm dispute is among the clearest examples of what happens when those terms are tested in court.
The case has drawn attention for a second reason: it puts a price on legal uncertainty itself. Companies negotiating licenses today do so without knowing where a Delaware jury will draw a fair boundary, which makes every new contract a bet on an unmade decision. Arm’s business depends on the breadth of its licensing base, and a verdict that narrows its terms would ripple through a customer list that includes most of the largest chip designers in the world.
The money at stake explains the persistence. Damages measured in the billions would matter both to Arm’s royalty stream and to Qualcomm’s cost of doing business, and a ruling either way would reset expectations for licensing deals that have not yet been signed. That is a large enough prize to keep both sides arguing through a mistrial and a retrial.
Court schedules in complex contract cases tend to slip, and a second trial would not likely begin soon. The delay is itself a cost, because the products at issue ship on annual cycles while litigation moves on a slower clock.
The unresolved part is what a second round would produce that the first did not. The two companies have argued over the same contract language for years, and the disagreement is less about facts a jury can weigh than about what the words were meant to cover. Whether a new panel, a judge or a settlement gets them past that question is exactly what the deadlock could not answer.
